Ambrx
Pioneer and Leader in Next Generation Antibody Drug Conjugates Using Engineered Precision Biologics
58 employees · est. 2003 · San Diego, United States
ProfoundBio
An oncology biotherapeutics company
8 employees · est. 2018 · Woodinville, United States
Ambrx is the older company (2003 vs 2018); Ambrx is the larger of the two.
Side-by-Side Comparison
| Metric | Ambrx | ProfoundBio |
|---|---|---|
| Founded | ||
| Founded | 2003 older | 2018 |
| Headquarters | ||
| Headquarters | San Diego, United States | Woodinville, United States |
| Employees | ||
| Employees | 58 larger | 8 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Series B |
| Total Funding | ||
| Total Funding | $2.55B | $247.00M |
| Funding Rounds | ||
| Funding Rounds | 11 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibody Drug Conjugates, Next Generation Therapies, Precision Biologics, Genetic Code Expansion, Immune System Modulation, Cancer Treatment, Prostate-Specific Membrane Antigen, HER2 Targeting, Protein Engineering, Biopharmaceutical Development, Clinical Stage Programs, Preclinical Programs | Antibody-based Therapeutics, Clinical-stage, Cancer Research, ADC Drug Candidates, Solid Tumors, Hematological Malignancies, Proprietary Technology, Seattle, Cancer Treatment, Innovative Drug Development, Oncology, Targeted Therapy, Precision Medicine |
| Website | ||
| Website | ambrx.com | profoundbio.com |
About Ambrx
Ambrx, founded in 2003 as a spin-out from The Scripps Research Institute, is a clinical stage biopharmaceutical company listed on Nasdaq under the ticker AMAM. Positioning itself as a pioneer and leader in its field, Ambrx employs an innovative expanded genetic code technology platform to develop ne...
About ProfoundBio
ProfoundBio is a clinical-stage biotechnology company founded in 2018. The company is focused on developing novel antibody-based therapeutics with curative potential for patients with cancer. ProfoundBio has a pipeline of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Ambrx and ProfoundBio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Ambrx and ProfoundBio — by email.
Frequently Asked Questions
Compare Ambrx with someone else
Start typing a company name or domain.